Protective effects of 'Khamira Abresham Hakim Arshad Wala', a unani formulation against doxorubicin-induced cardiotoxicity and nephrotoxicity

Toxicology Mechanisms and Methods

Volumn 21, Issue 1, 2011, Pages 41-47

  Nazmi, Abul Salam ^a   Ahmad, Shibli Jameel ^a   Rashikh, Azhar ^a   Akhtar, Mohammad ^a   Pillai, Krishna Kolappa ^a   Najmi, Abul Kalam ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Cardiotoxicity; Doxorubicin; Khamira Abresham Hakim Arshadwala; Nephrotoxicity; Unani medicine.

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CARDIOTONIC AGENT; CATALASE; CREATININE; DOXORUBICIN; GLUTATHIONE; KHAMIRA ABRESHAM HAKIM ARSHADWALA; LACTATE DEHYDROGENASE; LIPID PEROXIDE; NITROGEN; UNCLASSIFIED DRUG; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOTOXICITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ASPARTATE AMINOTRANSFERASES; BLOOD UREA NITROGEN; CREATININE; DOXORUBICIN; HEART DISEASES; KIDNEY DISEASES; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; MEDICINE, UNANI; PHYTOTHERAPY; PLANT PREPARATIONS; PLANTS, MEDICINAL; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 78650437679     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2010.529188     Document Type: Article

References (57)

1. Abdelwahed A, Bouhlel I, Skandrani I, Valenti K, Kadri M, Guiraud P, Steiman R, Mariotte AM, Ghedira K, Laporte F, Dijoux-Franca MG, Chekir-Ghedira L. 2007. Study of antimutagenic and antioxidant activities of gallic acid and 1,2,3,4,6-pentagalloylglucose from Pistacia lentiscus. Confrmation by microarray expression profling. Chem Biol Interact 165:1-13.
2. Abdel-Wahhab MA, Aly SE. 2005. Antioxidant property of Nigella sativa (black cumin) and Syzygium aromaticum (clove) in rats during afatoxicosis. J Appl Tox 25:218-223.
3. Afanas'ev IB, Dorozhko AI, Brodskii AV, Kostyuk SA, Potapovitch AI. 1989. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol 38:1763-1769.
4. Arafa HM, Abd-ellah MF, Hafez HF. 2005. Abatement by naringenin of doxorubicin-induced cardiac toxicity in rats. J Egyptian Nat Cancer Inst 17:291-300.
5. Belur B, Kandaswamy N, Mukherjee KL. 1990. Laboratory technology-A procedure manual for routine diagnostic tests. Delhi: Tata McGraw Hill Co. Ltd. pp 1124-1188.
6. Bernard J. 1967. Acute leukemia treatment. Cancer Res 26:2565-2569.
7. Beutler IR, Duron O, Kelly BM. 1963. Improved method of determination of blood glutathione. J Lab Clin Med 61:882-888.
8. Bones RW, Tausky HH. 1945. Te colorimetric determination of creatinine by Jafe reaction. J Biol Chem 158:581.
9. Carter SK. 1972. Single and combination nonhormonal chemotherapy in breast cancer. Cancer 30:1540-1555.
10. Chularojmontri L, Wattanapitayakul SK., Herunsalee A, Charuchongkolwongse S, Niumsakul S, Srichairat S. 2005. Antioxidative and cardioprotective efects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity. Biol Pharm Bull 28:1165-1171.
11. Cories EP, Ellison RR, Yates JN. 1972. Adriamycin in the treatment of acute myelocytic leukemia. Cancer Chemotherapy Rep 1:237-243.
12. Dash R, Acharya C, Bindu PC, Kundu SC. 2008. Antioxidant potential of silk protein sericin against hydrogen peroxide-induced oxidative stress in skin fbroblasts. BMB Rep 41:236-241.
13. Davidson MH, Maki KC, Dicklin MR, Feinstein SB, Witchger M, Bell M, McGuire DK, Provost JC, Liker H, Aviram M. 2009. Efects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. Am J Cardiol 104:936-942.
14. Deepa PR, Varalakshmi P. 2003. Protective efect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamy-cin-induced cardiac and hepatic toxicity. Chem Biol Interact 146: 201-210.
15. Doroshow JH. 1983. Efect of anthracycline antibiotics on oxygen free radical formation in rat heart. Cancer Res 43:460-472.
16. Dziegiel P, Jethon Z, Suder E, Sopel M, Rabczynski J, Surowiak P, Zabel M. 2002. Role of exogenous melatonin in reducing the cardiotoxic efect of dauno-rubicin and doxorubicin in the rat. Exp. Toxicol Pathol 53:433-439. (Pubitemid 34204953)
17. Elberry AA, Abdel-Naim AB, Abdel-Sattar EA, Nagy AA, Mosli HA, Mohamadin AM, Ashour OM. 2010. Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats. Food Chem Toxicol 48:1178-1184.
18. El-Shitany NA., El-Haggar S, El-desoky K. 2008. silymarin prevents adriamy-cin induced cardiotoxicity and nephrotoxicity in rats. Food Chem Toxic 46:2422-2428.
19. Evans CW. 1996. Trease and Evans' pharmacognosy. London: W.B. Sauders. pp 612.
20. Goyal S, Siddiqui MK, Siddiqui KM, Arora S, Mittal R, Joshi S, Arya DS. 2010. Cardioprotective efect of 'Khamira Abresham Hakim Arshad Wala' a Unani formulation in isoproterenol-induced myocardial necrosis in rats. Exp Toxicol Pathol 62:61-74.
21. Hirayama C, Ono H, Tamura Y, Nakamura M. 2006. C-prolinylquercetins from the yellow cocoon shell of the silkworm, Bombyx mori. Phytochemistry 67:579-583.
22. Jiao S, Huang C, Wang H, Yu S. 2007. Efects of citrus aurantium extract on liver antioxidant defense function in experimental diabetic mouse. Wei Sheng Yan Jiu 36:689-692.
23. Khan M, Chandra J, Krishna I, Umamaheshwara M, Naidu R, Kutala V. 2005. Protective efect ofspirulina against doxorubicin induced cardiotoxicity. Phytother Res 19:1031-1035.
24. Khan MB, Hoda MN, Yousuf S, Ishrat T, Ahmad M, Ahmad AS, Alavi SH, Haque N, Islam F. 2006. Prevention of cognitive impairments and neurodegen-eration by Khamira Abresham Hakim Arshad Wala. J Ethnopharmacol 108:68-73.
25. Kishore RK, Sudhakar D, Parthasarathy PR. 2009. Embryo protective efect of pomegranate (Punica granatum L.) fruit extract in adriamycin-induced oxidative stress. Ind J Biochem Biophys 46:106-11.
26. Kotamraju S, Konorev EA, Joseph J. 2000. Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem 275:33585-33592.
27. Kumar D, Kirshenbaum, L.A., Danelisen, I., Singal, P.K. 2001. Apoptosis in adri-amycin cardiomyopathy and its modulation by probucol. Antioxid Redox Signal 3:135-145.
28. Kurioka A, Yamazaki M. 2002. Purifcation and identifcation of favonoids from the yellow green cocoon shell (Sasamayu) of the silkworm, Bombyx mori. Biosc Biotechnol Biochem 66:1396-1399.
29. Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. 1973. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32:302-314.
30. Leontowicz M, Gorinstein S, Leontowicz H, Krzeminski R, Lojek A, Katrich E, Cíz M, Martin-Belloso O, Soliva-Fortuny R, Haruenkit R, Trakhtenberg S. 2003. Apple and pear peel and pulp and their infuence on plasma lipids and antioxidant potentials in rats fed cholesterol-containing diets. J Agr Food Chem 51:5780-5785.
31. Liu L, Shan S, Zhang K, Ning ZQ, Lu X P, Cheng YY. 2008. Naringenin and hes-peretin, two favonoids derived from citrus aurantium up-regulate transcription of adiponectin. Phytother Res 22:1400-1403.
32. Lowry OH, Rosenburg NJ, Farr AL, Randall RJ. 1951. Protein measurement with Folin phenol reagent. J Biol Chem 193:265-275.
33. Luck H. 1971. Catalase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. New York: New York Academic Press. pp 885-893.
34. Lum G, Gambino SR. 1974. A comparison of serum versus heparinised plasma for routine chemistry tests. Am J Clin Pathol 61:108-113.
35. Lyle N, Bhattacharyya D, Munshi S, Chatterjee S, Gomes A. 2009. Stress modulating antioxidant efect of Nardostachys jatamansi. Ind J Biochem Biophys 46:93-98.
36. Mishra A, Bhatti R, Singh A, Singh IMP. 2010. Ameliorative efect of the cinnamon oil from cinnamomum zeylanicum upon early stage diabetic neph-ropathy. Planta Med 76:412-417.
37. Myers CE. 1982. Te role of free radical damage in the genesis of doxoru-bicin cardiac toxicity. In: Muggia FM, Young CW, Carters K, editors. Anthracycline antibiotics in cancer chemotherapy. Te Hague: Martinus Nijhof. pp 297-305.
38. Myers CE, McGuire WP, Liss RH, Ifrim I, Grotzinger K, Young RC. 1977. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 197:165-167.
39. Ohkawa H, Oshishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 95:351-358.
40. Pinna A, Agen C, Di Paolo A, Innocenti F, Nardini D, Danesi R, Del Tacca M. 1994. Dissociation between in vitro cytotoxicity and in vivo cardiotoxic-ity of two new anthracyclines: 3'-deamino-3'-(2-methoxy-4-morpholinyl) doxorubicin and 4'-deoxy-4'-iodo-doxorubicin. J Environ. Pathol Toxicol Oncol 13:25-31.
41. Rajaprabhu D, Rajesh R, Jeyakumar R, Buddhan S, Ganesan B, Anandan R. 2007. Protective efect of Picrorhiza kurroa on antioxidant defense status in adriamycin-induced cardiomyopathy in rats. J Med Plant Res 1:80-85.
42. Reitman S, Frankel AS. 1957. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transminases. Am J Clin Pathol 28:53-56.
43. Saad SY, Najjar TA, Al-Rikabi AC. 2001. Te preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res 43:211-218.
44. Scholey JW, Miller PL, Rennke HG, Meyer TW. 1989. Efect of converting enzyme inhibition on the course of adriamycin induced nephropathy. Kidney Int 36:816-822.
45. Sedlack J, Lindsay RH. 1968. Estimation of total, protein bound and non-protein bound sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 25:192-205.
46. Sengul M, Yildiz H, Gungor N, Cetin B, Ercisli S. 2009. Total phenolic content, antioxidant and antimicrobial activities of some medicinal plants. Pak J Pharm Sci 22:102-106.
47. Singal PK, Deally CM, Weinberg LE. 1987. Subcellular efects of adriamycin in the heart: a concise review. J Mol Cell Cardiol 19:817-828.
48. Singal PK, Iliskovic N. 1998. Doxorubicin-induced cardiomyopathy. N Eng J Med 339:900-905.
49. Siveski-Iliskovic N, Hill M, Chow DA. 1995. Probucol protects against adri-amycin cardiomyopathy without interfering with its antitumor efect. Circulation 91:10-15.
50. Straubinger M, Jezussek M, Waibel R, Winterhalter P. 1997. Two kaempferol sophorosides from Crocus sativus. Nat Prod Lett 10:213-216.
51. Subashini R, Yogeeta S, Gnanapragasam A, Devaki T. 2006. Protective efect of Nardostachys jatamansi on oxidative injury and cellular abnormalities during doxorubicin-induced cardiac damage in rats. J Pharm Pharmacol 58:257-262.
52. Teitz NW. 1976. Clinical guide to laboratory test. Philadelphia: WB Saunders Co. pp 238.
53. Wahab MH, El-Mahdy MF, Helal GK, Khalifa F, Hamada FMA. 2003. Infuence of p-coumaric acid on doxorubicin induced oxidative stress in rats heart. Pharmac Res 48:461-465.
54. Wattanapitayakul SK, Chularojmontri L, Herunsalee A, Charuchongkolwongse S, Niumsakul S, Bauer JA. 2005. Screening of antioxidants from medicinal plants for cardioprotective efect against doxorubicin toxicity. Basic Clin Pharmacol Toxicol 96:80-87.
55. WHO. 2002. Traditional medicine; Growing needs and potential. WHO policy perspectives on medicines. Geneva: World Health Organization. pp 1-6.
56. Yilmaz S, Atessahin A, Sahna E, Ozers. 2006. Protective efect of lycopen on adriamycin-induced cardiotoxicity nephrotoxicity. Toxicology 218: 164-171.
57. Yin X, Wu H, Chen Y, Kang YJ. 1998. Induction of antioxidants by adriamycin in mouse heart. Biochem Pharmacol 56:87-93.